UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How I treat thalassemia

Blood, 2011-09, Vol.118 (13), p.3479-3488

2011

Volltextzugriff (PDF)

Bone loss caused by iron overload in a murine model: importance of oxidative stress

Blood, 2010-10, Vol.116 (14), p.2582-2589

2010

Volltextzugriff (PDF)

Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients

PloS one, 2012-03, Vol.7 (3), p.e32345-e32345

2012

Volltextzugriff (PDF)

Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

Journal of bone and mineral research, 2009-03, Vol.24 (3), p.543-557

2009

Volltextzugriff (PDF)

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine

Haematologica (Roma), 2013-01, Vol.98 (1), p.129-135

2013

Volltextzugriff (PDF)

Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea

PloS one, 2013-02, Vol.8 (2), p.e55709-e55709

2013

Volltextzugriff (PDF)

Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia

Nature medicine, 2013-04, Vol.19 (4), p.437-445

2013

Volltextzugriff (PDF)

Inflammation and oxidant-stress in β-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine : an ancillary study of the Novartis CICL670A0107 trial

Haematologica (Roma), 2008-06, Vol.93 (6), p.817-825

2008

Volltextzugriff (PDF)

Relationship between Chronic Transfusion Therapy and Body Composition in Subjects with Thalassemia

The Journal of pediatrics, 2010-10, Vol.157 (4), p.641-647.e2

2010

Volltextzugriff (PDF)

Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)

Transfusion (Philadelphia, Pa.), 2014-04, Vol.54 (4), p.972-981

2014

Volltextzugriff (PDF)

Safety and efficacy of pegylated interferon α-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia

Haematologica (Roma), 2008-08, Vol.93 (8), p.1247-1251

2008

Volltextzugriff (PDF)

An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres

British journal of haematology, 2022-01, Vol.196 (2), p.380-389

2022

Volltextzugriff (PDF)

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice

The Journal of clinical investigation, 2010-12, Vol.120 (12), p.4466-4477

2010

Volltextzugriff (PDF)

Combined iron chelation therapy

Annals of the New York Academy of Sciences, 2010-08, Vol.1202 (1), p.79-86

2010

Volltextzugriff (PDF)

Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

Blood, 2007-06, Vol.109 (11), p.5027-5035

2007

Volltextzugriff (PDF)

Renal dysfunction in patients with thalassaemia

British journal of haematology, 2011-04, Vol.153 (1), p.111-117

2011

Volltextzugriff (PDF)

Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America

British journal of haematology, 2009-09, Vol.146 (5), p.546-556

2009

Volltextzugriff (PDF)

Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort

Blood, 2012-03, Vol.119 (12), p.2746-2753

2012

Volltextzugriff (PDF)

Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemia

Blood, 2008-08, Vol.112 (3), p.875-885

2008

Volltextzugriff (PDF)

Late complications of mixed chimerism following allogeneic bone marrow transplantation for thalassemia major

Pediatric blood & cancer, 2015-07, Vol.62 (7), p.1303-1304

2015

Volltextzugriff (PDF)

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

The Lancet (British edition), 2003-05, Vol.361 (9369), p.1597-1602

2003

Volltextzugriff (PDF)

Iron chelation adherence to deferoxamine and deferasirox in thalassemia

American journal of hematology, 2011-05, Vol.86 (5), p.433-436

2011

Volltextzugriff (PDF)

Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease

Pediatric blood & cancer, 2013-04, Vol.60 (4), p.653-658

2013

Volltextzugriff (PDF)

The palatability and tolerability of deferasirox taken with different beverages or foods

Pediatric blood & cancer, 2013-09, Vol.60 (9), p.1507-1512

2013

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(133)

Publikationsform

Artikel
(148)
Berichte
(1)

Sprache

Englisch
(149)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Humans
(78)
Science & Technology
(70)
Life Sciences & Biomedicine
(67)
Female
(51)
Hematology
(49)
Male
(49)
Adult
(44)
Biological And Medical Sciences
(40)
Adolescent
(39)
Medical Sciences
(37)
Hematologic And Hematopoietic Diseases
(35)
Child
(34)
Anemias. Hemoglobinopathies
(33)
Diseases Of Red Blood Cells
(33)
Child, Preschool
(24)
Middle Aged
(22)
Thalassemia
(20)
Young Adult
(18)
Beta-Thalassemia - Therapy
(16)
Blood Transfusion
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

How I treat thalassemia

Bone loss caused by iron overload in a murine model: importance of oxidative stress

A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD)

Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients

Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine

Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea

Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia

Inflammation and oxidant-stress in β-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine : an ancillary study of the Novartis CICL670A0107 trial

Relationship between Chronic Transfusion Therapy and Body Composition in Subjects with Thalassemia

Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)

Safety and efficacy of pegylated interferon α-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia

An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice

Combined iron chelation therapy

Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

Renal dysfunction in patients with thalassaemia

Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America

Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort

Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemia

Late complications of mixed chimerism following allogeneic bone marrow transplantation for thalassemia major

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

Iron chelation adherence to deferoxamine and deferasirox in thalassemia

Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease

The palatability and tolerability of deferasirox taken with different beverages or foods

Suchergebnisse filtern